Bonechi, M., Galardi, F., Biagioni, C., De Luca, F., Bergqvist, M., Neumüller, M., . . . Malorni, L. (2018). Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy. Oncotarget.
Citación estilo ChicagoBonechi, Martina, et al. "Plasma Thymidine Kinase-1 Activity Predicts Outcome in Patients With Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer Treated With Endocrine Therapy." Oncotarget 2018.
Cita MLABonechi, Martina, et al. "Plasma Thymidine Kinase-1 Activity Predicts Outcome in Patients With Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer Treated With Endocrine Therapy." Oncotarget 2018.